Is there a role for autotransplants in patients with follicular lymphoma in the rituximab era?

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Patients with low grad follicular lymphoma were shown to be able to achieve long-term disease-free survival when transplanted after relapse in the era before the wide spread use of rituximab. It appears that the availability of rituximab has not diminished the value of transplantation (i.e., either autologous or allogeneic) in the care of these patients. A similar overall survival and less treatment related toxicity make autologous transplantation the better choice for most patients transplanted at first treatment failure.

Original languageEnglish (US)
Pages (from-to)24-26
Number of pages3
JournalTransfusion and Apheresis Science
Volume49
Issue number1
DOIs
StatePublished - Aug 1 2013

Fingerprint

Follicular Lymphoma
Autografts
Autologous Transplantation
Treatment Failure
Disease-Free Survival
Patient Care
Transplantation
Recurrence
Survival
Rituximab
Therapeutics

ASJC Scopus subject areas

  • Hematology

Cite this

Is there a role for autotransplants in patients with follicular lymphoma in the rituximab era? / Armitage, James Olen.

In: Transfusion and Apheresis Science, Vol. 49, No. 1, 01.08.2013, p. 24-26.

Research output: Contribution to journalArticle

@article{d7755ec8cdcd44488961f504448ef684,
title = "Is there a role for autotransplants in patients with follicular lymphoma in the rituximab era?",
abstract = "Patients with low grad follicular lymphoma were shown to be able to achieve long-term disease-free survival when transplanted after relapse in the era before the wide spread use of rituximab. It appears that the availability of rituximab has not diminished the value of transplantation (i.e., either autologous or allogeneic) in the care of these patients. A similar overall survival and less treatment related toxicity make autologous transplantation the better choice for most patients transplanted at first treatment failure.",
author = "Armitage, {James Olen}",
year = "2013",
month = "8",
day = "1",
doi = "10.1016/j.transci.2013.05.020",
language = "English (US)",
volume = "49",
pages = "24--26",
journal = "Transfusion and Apheresis Science",
issn = "1473-0502",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Is there a role for autotransplants in patients with follicular lymphoma in the rituximab era?

AU - Armitage, James Olen

PY - 2013/8/1

Y1 - 2013/8/1

N2 - Patients with low grad follicular lymphoma were shown to be able to achieve long-term disease-free survival when transplanted after relapse in the era before the wide spread use of rituximab. It appears that the availability of rituximab has not diminished the value of transplantation (i.e., either autologous or allogeneic) in the care of these patients. A similar overall survival and less treatment related toxicity make autologous transplantation the better choice for most patients transplanted at first treatment failure.

AB - Patients with low grad follicular lymphoma were shown to be able to achieve long-term disease-free survival when transplanted after relapse in the era before the wide spread use of rituximab. It appears that the availability of rituximab has not diminished the value of transplantation (i.e., either autologous or allogeneic) in the care of these patients. A similar overall survival and less treatment related toxicity make autologous transplantation the better choice for most patients transplanted at first treatment failure.

UR - http://www.scopus.com/inward/record.url?scp=84882829821&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882829821&partnerID=8YFLogxK

U2 - 10.1016/j.transci.2013.05.020

DO - 10.1016/j.transci.2013.05.020

M3 - Article

VL - 49

SP - 24

EP - 26

JO - Transfusion and Apheresis Science

JF - Transfusion and Apheresis Science

SN - 1473-0502

IS - 1

ER -